BPC 157: The peptide with big claims and scant evidence STAT Peptides are surging in popularity. There's little evidence that they work. The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York The Peptide Split: How GLP 1s, Lutathera, Vosoritide, and Peptide Cancer Vaccines Are Quietly Rewriting Medicine While BPC 157, TB 500, MOTS c, and the Wellness Grift Borrow Their Halo Are Peptides Safe? What Older Adults Need to Know The peptide problem: Hype is outrunning the evidence